What is Obagi?
Headquartered in Long Beach, California, Obagi operates as a specialized manufacturer of clinical-grade skincare products. The company distinguishes itself through a comprehensive product portfolio designed to address the unique needs of every skin tone and type. By prioritizing scientific rigor and dermatological efficacy, Obagi has cultivated a strong reputation among both medical professionals and retail consumers. Its market position is defined by a commitment to inclusive skincare, ensuring that advanced formulations are accessible to a broad spectrum of users, thereby bridging the gap between professional-grade treatments and daily consumer routines.
How much funding has Obagi raised?
Obagi has raised a total of $58.9M across 1 funding round:
Stock Offering
$58.9M
Stock Issuance/Offering (2006): $58.9M, investors not publicly disclosed
Key Investors in Obagi
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Obagi?
Looking ahead, the strategic deployment of this capital is expected to focus on accelerating product innovation and deepening market penetration. With the backing of this major enterprise-level funding, Obagi is well-positioned to invest in research and development, potentially exploring new delivery systems or expanding its footprint in emerging international markets. The company's focus will likely remain on maintaining its high standards of product quality while scaling its supply chain to meet increasing global demand. By leveraging this financial momentum, Obagi aims to solidify its status as a cornerstone of the modern skincare industry, driving long-term value through sustained innovation and strategic market expansion.
See full Obagi company page
